- Home
- PGHL vs DMAC Comparison
PGHL vs DMAC Comparison
Compare PGHL & DMAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PGHL
- DMAC
- Stock Information
- Founded
- PGHL 2018
- DMAC 2000
- Country
- PGHL Hong Kong
- DMAC United States
- Employees
- PGHL N/A
- DMAC N/A
- Industry
- PGHL
- DMAC Biotechnology: Pharmaceutical Preparations
- Sector
- PGHL
- DMAC Health Care
- Exchange
- PGHL NYSE
- DMAC Nasdaq
- Market Cap
- PGHL 189.6M
- DMAC 185.1M
- IPO Year
- PGHL 2024
- DMAC N/A
- Fundamental
- Price
- PGHL $13.70
- DMAC $4.19
- Analyst Decision
- PGHL
- DMAC Strong Buy
- Analyst Count
- PGHL 0
- DMAC 3
- Target Price
- PGHL N/A
- DMAC $7.00
- AVG Volume (30 Days)
- PGHL 126.7K
- DMAC 34.2K
- Earning Date
- PGHL 11-15-2024
- DMAC 11-13-2024
- Dividend Yield
- PGHL N/A
- DMAC N/A
- EPS Growth
- PGHL N/A
- DMAC N/A
- EPS
- PGHL 0.05
- DMAC N/A
- Revenue
- PGHL $13,464,430.00
- DMAC N/A
- Revenue This Year
- PGHL N/A
- DMAC N/A
- Revenue Next Year
- PGHL N/A
- DMAC N/A
- P/E Ratio
- PGHL $287.21
- DMAC N/A
- Revenue Growth
- PGHL 20.83
- DMAC N/A
- 52 Week Low
- PGHL $3.60
- DMAC $2.12
- 52 Week High
- PGHL $22.50
- DMAC $4.95
- Technical
- Relative Strength Index (RSI)
- PGHL N/A
- DMAC 45.24
- Support Level
- PGHL N/A
- DMAC $4.14
- Resistance Level
- PGHL N/A
- DMAC $4.48
- Average True Range (ATR)
- PGHL 0.00
- DMAC 0.18
- MACD
- PGHL 0.00
- DMAC -0.03
- Stochastic Oscillator
- PGHL 0.00
- DMAC 34.88
About PGHL PRIMEGA GROUP HOLDINGS LIMITED
Primega Group Holdings Ltd is engaged in transportation services. It operate in the Hong Kong construction industry, mainly handling transportation of materials excavated from construction sites. Its services principally comprise of (i) soil and rock transportation services; (ii) diesel oil trading; and (iii) construction works, which mainly includes ELS works and bored piling. The company provide services as a subcontractor to other construction contractors in Hong Kong. Maximum revenue is generated from oil and rock transportation services.
About DMAC DiaMedica Therapeutics Inc.
DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is principally engaged in the business activity of developing treatments for unmet clinical needs or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pipeline product DM199 is a recombinant form of human tissue kallikrein-1.